My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 271

    1.

    In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control.

    Pistrosch F, Passauer J, Fischer S, Fuecker K, Hanefeld M, Gross P.

    Diabetes Care. 2004 Feb;27(2):484-90.PMID: 14747233 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.

    Tack CJ, Ong MK, Lutterman JA, Smits P.

    Diabetologia. 1998 May;41(5):569-76.PMID: 9628275 [PubMed - indexed for MEDLINE]Related articles

    3.

    Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes.

    Natali A, Baldeweg S, Toschi E, Capaldo B, Barbaro D, Gastaldelli A, Yudkin JS, Ferrannini E.

    Diabetes Care. 2004 Jun;27(6):1349-57.PMID: 15161787 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Rosiglitazone improves exercise capacity in individuals with type 2 diabetes.

    Regensteiner JG, Bauer TA, Reusch JE.

    Diabetes Care. 2005 Dec;28(12):2877-83.PMID: 16306548 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients.

    Pistrosch F, Herbrig K, Kindel B, Passauer J, Fischer S, Gross P.

    Diabetes. 2005 Jul;54(7):2206-11.PMID: 15983223 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.

    Osei K, Gaillard T, Schuster D.

    Metabolism. 2007 Jan;56(1):24-9.PMID: 17161222 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of pioglitazone on endothelial function, insulin sensitivity, and glucose control in subjects with coronary artery disease and new-onset type 2 diabetes.

    Sourij H, Zweiker R, Wascher TC.

    Diabetes Care. 2006 May;29(5):1039-45.PMID: 16644634 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial.

    McSorley PT, Bell PM, Young IS, Atkinson AB, Sheridan B, Fee JP, McCance DR.

    Diabet Med. 2005 Jun;22(6):703-10.PMID: 15910620 [PubMed - indexed for MEDLINE]Related articles

    9.

    PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells.

    Pistrosch F, Herbrig K, Oelschlaegel U, Richter S, Passauer J, Fischer S, Gross P.

    Atherosclerosis. 2005 Nov;183(1):163-7.PMID: 15907852 [PubMed - indexed for MEDLINE]Related articles

    10.

    High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance.

    Chen H, Karne RJ, Hall G, Campia U, Panza JA, Cannon RO 3rd, Wang Y, Katz A, Levine M, Quon MJ.

    Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H137-45. Epub 2005 Aug 26.PMID: 16126809 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride.

    Pfützner A, Schöndorf T, Seidel D, Winkler K, Matthaei S, Hamann A, Forst T.

    Metabolism. 2006 Jan;55(1):20-5.PMID: 16324915 [PubMed - indexed for MEDLINE]Related articles

    12.

    Rosiglitazone prevents free fatty acid-induced vascular endothelial dysfunction.

    Mittermayer F, Schaller G, Pleiner J, Krzyzanowska K, Kapiotis S, Roden M, Wolzt M.

    J Clin Endocrinol Metab. 2007 Jul;92(7):2574-80. Epub 2007 May 1.PMID: 17473072 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms.

    Fernandez M, Triplitt C, Wajcberg E, Sriwijilkamol AA, Musi N, Cusi K, DeFronzo R, Cersosimo E.

    Diabetes Care. 2008 Jan;31(1):121-7. Epub 2007 Oct 1.PMID: 17909084 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control.

    Fonseca V, Grunberger G, Gupta S, Shen S, Foley JE.

    Diabetes Care. 2003 Jun;26(6):1685-90.PMID: 12766094 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes.

    Martens FM, Visseren FL, de Koning EJ, Rabelink TJ.

    J Cardiovasc Pharmacol. 2005 Dec;46(6):773-8.PMID: 16306801 [PubMed - indexed for MEDLINE]Related articles

    16.

    Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.

    Yu Y, Suo L, Yu H, Wang C, Tang H.

    Diabetes Res Clin Pract. 2004 Aug;65(2):95-104.PMID: 15223221 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial.

    Tan M, Johns D, González Gálvez G, Antúnez O, Fabián G, Flores-Lozano F, Zúñiga Guajardo S, Garza E, Morales H, Konkoy C, Herz M; GLAD Study Group.

    Clin Ther. 2004 May;26(5):680-93.PMID: 15220012 [PubMed - indexed for MEDLINE]Related articles

    18.

    Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients.

    Voytovich MH, Simonsen C, Jenssen T, Hjelmesaeth J, Asberg A, Hartmann A.

    Nephrol Dial Transplant. 2005 Feb;20(2):413-8. Epub 2004 Dec 22.PMID: 15615809 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Impaired endothelial function and insulin action in first-degree relatives of patients with type 2 diabetes mellitus.

    Sonne MP, Højbjerre L, Alibegovic AA, Vaag A, Stallknecht B, Dela F.

    Metabolism. 2009 Jan;58(1):93-101.PMID: 19059536 [PubMed - indexed for MEDLINE]Related articles

    20.

    Improved endothelial function with metformin in type 2 diabetes mellitus.

    Mather KJ, Verma S, Anderson TJ.

    J Am Coll Cardiol. 2001 Apr;37(5):1344-50.PMID: 11300445 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity